Innovation Beyond Borders: New Approaches Transforming Health | Global Conference 2025

Core Philosophy and Systemic Shifts

• Reframing Healthcare Models: The consensus is that current systems are inherently reactive, focusing on managing lifespan rather than extending healthy lifespan or prioritizing prevention.
• Holistic Determinants: Approximately 80% of health outcomes are determined by factors outside the clinical walls, including nutrition, sleep, social connections, and environment.
• Definition of Roles: The speaker proposes shifting terminology from "patient" to "individual" to remove the assumption of illness and emphasize a 360-degree view of health from birth to death.
• Economic Imperative: Thriving economies are directly dependent on the quality and health of their populations, necessitating a move away from siloed approaches.
• Longevity as a Right: There is a stated goal that longevity and quality health should be considered a birthright rather than a privilege, requiring access to 360-degree care.

Pharmaceutical Industry Evolution

• Expanded Scope: While pharmaceutical companies traditionally treat disease, the industry is pivoting to include prevention through vaccines and early intervention.
• Vaccine Impact: Vaccines are identified as the second most effective health intervention globally after clean water, having avoided 150 million deaths in the last 50 years.
• Preventive Therapeutics: Sanofi launched a treatment for Type 1 diabetes designed to delay disease onset rather than treat existing symptoms by intervening before beta cell autodestruction occurs.
• RSV Intervention: A novel RSV prevention treatment reduced hospitalization rates in babies by 82% in real-world evidence, covering six million infants globally in the last year.
• Regulatory Partnerships: Success in preventive trials requires negotiation with regulators (e.g., FDA) to define novel endpoints, such as delaying disease onset, rather than traditional clinical endpoints.
• Timeline Challenges: Developing preventive therapies often requires long-term trials; the Type 1 diabetes solution took over 13 years to bring to market due to the need for long-term follow-up.

Technology and Data Infrastructure

• Integration of Disparate Data: Key barriers to prevention include the lack of mechanisms to combine lifestyle data (wearables, glucose monitors) with Electronic Medical Records (EMR) and hospital data.
• Population Health Intelligence Platforms: Abu Dhabi has built a unified platform integrating clinical data, 30x genomic sequencing, wearable lifestyle data, and environmental data to enable prediction, prevention, and personalized intervention.
• Incentive Misalignment: Current global reimbursement and fee-for-service models incentivize treatment and procedures, leaving prevention underfunded and under-reimbursed.
• Catalytic Capital: There is a need for patient capital to bridge the gap between innovation and scale, as preventive business models often require longer time horizons for ROI.

AI and Ambient Technologies

• Ambient AI in Screening: CURE utilizes "ambient AI" to analyze 1.3 billion annual chest X-rays to identify lung nodules, triaging only high-risk individuals for CT scans, increasing screening efficiency significantly.
• Diagnostic Triage: A malignancy risk score study found that 54 out of 100 patients flagged by AI as high-risk via X-ray had positive CT results, while 95 had negative results, demonstrating high predictive value.
• Automated Scribing: Ambient AI is being used to transcribe doctor-patient conversations in real-time, capturing family history and risk factors that might otherwise be missed during busy clinical visits.
• Augmentation vs. Replacement: Experts argue AI will act as an augmentative tool for physicians and healthcare workers, particularly in regions with staff shortages, rather than replacing doctors entirely in the next 5–10 years.
• Data Sovereignty and Security: Abu Dhabi enforces strict data sovereignty, ensuring health data remains encrypted, de-anonymized when shared, and protected by federal law similar to banking infrastructure.

Regulatory and Policy Frameworks

• Surrogate Endpoints: Regulators are increasingly open to using surrogate markers to accelerate the approval of preventive therapies, provided there is scientific consensus on their predictive value.
• Genomic Inclusivity: Current genomic databases are skewed; Abu Dhabi's mandatory pre-marital screening program addresses this by sequencing diverse populations to identify genetic compatibilities and reduce hereditary diseases.
• Cross-Sector Integration: Abu Dhabi established a "Healthy Living Unit" reporting directly to the health leadership to coordinate policies across schools, municipalities, and labor regarding diet and exercise.
• Replicability: The Abu Dhabi model suggests that integrated systems with population-level visibility can be replicated elsewhere, provided there is political will and courageous policy decisions.
• Global Health Equity: There is a push to export centers of excellence (e.g., UAE and Japan) to regions like South Asia and Africa, leveraging accepted regulatory frameworks to speed up the deployment of health solutions.

Challenges and Future Outlook

• Human-AI Trust Gap: Successful adoption of AI requires integrating trained healthcare professionals into the design process to avoid behavioral rejection of technological solutions.
• Bias Mitigation: Reducing AI bias requires training on massive, diverse datasets to ensure algorithms do not perpetuate health disparities based on race, geography, or socioeconomic status.
• Infrastructure as Prevention: Prevention is viewed as requiring significant infrastructure investment comparable to building roads or electricity lines to support sustainable systems.
• Data Granularity: Future EMRs should ideally include variable data, genomic sequencing, and social determinants of health to enable AI-driven precision medicine.
• Universal Health Coverage (UHC): The shift toward UHC and universal coverage is seen as a mechanism to naturally embed prevention into the healthcare ecosystem.